FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3139148862> ?p ?o ?g. }

• W3139148862 endingPage "3997" @default.
• W3139148862 startingPage "3997" @default.
• W3139148862 abstract "Abstract Molecular classification of the different nodal peripheral T-cell lymphoma (PTCL) entities is not yet clarified, and this particularly applies to the two main clinical subtypes: angio-immunoblastic T-lymphomas (AITL) and PTCL-not otherwise specified (PTCL-NOS). Previous studies have shown that these two entities bear distinct gene expression profiles (GEP) that allow their distinction. However, clinical usage of GEP has been limited due to its complexity and to the absence of a well validated signature. Following the recent advances in next generation sequencing (NGS), three recurrently mutated genes (RHOA , TET2 , DNMT3A ) were found in approximately 60-70% of AITL and in 20-30% of PTCL-NOS. In addition, 20-30% of AITLs cases are characterized by a hotspot IDH2R172 mutation that is generally absent in PTCL-NOSs. Furthermore, the interrelationship of the mutations with the AITL/PTCL-NOS GEP classification has not been comprehensively evaluated. We collected and analyzed GEP data from available public PTCL studies (for a total of 503 cases: 127 AITL, 144 PTCL-NOS, 56 ALK-pos anaplastic large cell lymphoma (ALCL), 96 Alk-neg ALCL, 21 adult T-lymphoma/leukemia (ATLL), 59 NK/T-cell lymphomas. After correcting for any potential batch effect, the cases were re-classified based on published studies (Iqbal, Blood 2014). For 53 cases, mutational data for RHOA , TET2 , DNMT3A, and IDH2 genes (Wang, Blood 2015) were available and used to perform an integrated analysis to improve the current molecular classification between AITL and PTCL-NOS. As expected, ALK-neg and ALK-pos ALCLs, NK/T-cell lymphoma and ATLL were associated with distinct signatures; conversely, GEP of AITL and PTCL-NOS revealed significant overlap. To improve their distinction, we investigated the contribution of recurrent mutations to the transcriptional pattern, applying a recently published analysis (Gerstung, Nat Comm 2015) on 39 AITLs and 14 PTCL-NOSs for whom mutational data were available. Briefly, we created a model that included the lymphoma histotype, its gene expression profile, its genotype, and the age and gender of the patient. Interestingly, we observed how the mutational status of RHOA , TET2 and DNMT3A correlated poorly with the transcriptional profile of each case in both AITL and PTCL-NOS. RHOA mutations are known to be frequently subclonal, possibly explaining their little effect on gene expression. Conversely, TET2 and DNMT3A mutations are likely as early as hematopoietic stem cells mutations involved in clonal hemopoiesis, so that their effect on transcription may be lost during lymphoma development. Conversely, a strong transcriptional signature was identified in IDH2R172 samples consisting of 35 genes with False Discovery Rate (FDR) In this study, we provide a novel and reproducible bioinformatic approach to integrate clinical, expression and mutational data to improve the current molecular classification of PTCL. The presence of IDH2R217 mutations and the extent of PC infiltration could be used to differentiate AITL and PTCL-NOS in clinical practice, and this will be tested in future studies. Disclosures Chiappella: Pfizer: Speakers Bureau; Teva: Speakers Bureau; Amgen: Speakers Bureau; Celgene: Speakers Bureau; Roche: Speakers Bureau; Janssen: Speakers Bureau; Nanostring: Speakers Bureau. Zaja: Takeda: Honoraria; Janssem: Honoraria; Abbvie: Honoraria; Novartis: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Roche: Honoraria, Research Funding; Gilead: Honoraria. Corradini: Amgen: Honoraria; Sanofi: Honoraria; Takeda: Honoraria; Janssen: Honoraria; Celgene: Honoraria; Novartis: Honoraria; Roche: Honoraria; Gilead: Honoraria." @default.
• W3139148862 created "2021-03-29" @default.
• W3139148862 creator A5000403848 @default.
• W3139148862 creator A5004295563 @default.
• W3139148862 creator A5005229861 @default.
• W3139148862 creator A5014295233 @default.
• W3139148862 creator A5018309741 @default.
• W3139148862 creator A5022848854 @default.
• W3139148862 creator A5027878979 @default.
• W3139148862 creator A5028619240 @default.
• W3139148862 creator A5034090077 @default.
• W3139148862 creator A5039006383 @default.
• W3139148862 creator A5042629318 @default.
• W3139148862 creator A5042719564 @default.
• W3139148862 creator A5047767415 @default.
• W3139148862 creator A5051075507 @default.
• W3139148862 creator A5051379368 @default.
• W3139148862 creator A5051626849 @default.
• W3139148862 creator A5053560614 @default.
• W3139148862 creator A5061736991 @default.
• W3139148862 creator A5090133153 @default.
• W3139148862 creator A5090334148 @default.
• W3139148862 creator A5091566972 @default.
• W3139148862 date "2017-12-07" @default.
• W3139148862 modified "2023-10-18" @default.
• W3139148862 title "A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes" @default.
• W3139148862 doi "https://doi.org/10.1182/blood.v130.suppl_1.3997.3997" @default.
• W3139148862 hasPublicationYear "2017" @default.
• W3139148862 type Work @default.
• W3139148862 sameAs 3139148862 @default.
• W3139148862 citedByCount "0" @default.
• W3139148862 crossrefType "journal-article" @default.
• W3139148862 hasAuthorship W3139148862A5000403848 @default.
• W3139148862 hasAuthorship W3139148862A5004295563 @default.
• W3139148862 hasAuthorship W3139148862A5005229861 @default.
• W3139148862 hasAuthorship W3139148862A5014295233 @default.
• W3139148862 hasAuthorship W3139148862A5018309741 @default.
• W3139148862 hasAuthorship W3139148862A5022848854 @default.
• W3139148862 hasAuthorship W3139148862A5027878979 @default.
• W3139148862 hasAuthorship W3139148862A5028619240 @default.
• W3139148862 hasAuthorship W3139148862A5034090077 @default.
• W3139148862 hasAuthorship W3139148862A5039006383 @default.
• W3139148862 hasAuthorship W3139148862A5042629318 @default.
• W3139148862 hasAuthorship W3139148862A5042719564 @default.
• W3139148862 hasAuthorship W3139148862A5047767415 @default.
• W3139148862 hasAuthorship W3139148862A5051075507 @default.
• W3139148862 hasAuthorship W3139148862A5051379368 @default.
• W3139148862 hasAuthorship W3139148862A5051626849 @default.
• W3139148862 hasAuthorship W3139148862A5053560614 @default.
• W3139148862 hasAuthorship W3139148862A5061736991 @default.
• W3139148862 hasAuthorship W3139148862A5090133153 @default.
• W3139148862 hasAuthorship W3139148862A5090334148 @default.
• W3139148862 hasAuthorship W3139148862A5091566972 @default.
• W3139148862 hasConcept C104317684 @default.
• W3139148862 hasConcept C117643217 @default.
• W3139148862 hasConcept C126322002 @default.
• W3139148862 hasConcept C127848430 @default.
• W3139148862 hasConcept C203014093 @default.
• W3139148862 hasConcept C2776059313 @default.
• W3139148862 hasConcept C2776090121 @default.
• W3139148862 hasConcept C2776232967 @default.
• W3139148862 hasConcept C2776256026 @default.
• W3139148862 hasConcept C2777547418 @default.
• W3139148862 hasConcept C2777589544 @default.
• W3139148862 hasConcept C2777872185 @default.
• W3139148862 hasConcept C2777891184 @default.
• W3139148862 hasConcept C2778305200 @default.
• W3139148862 hasConcept C2779338263 @default.
• W3139148862 hasConcept C2781462825 @default.
• W3139148862 hasConcept C501734568 @default.
• W3139148862 hasConcept C502942594 @default.
• W3139148862 hasConcept C54355233 @default.
• W3139148862 hasConcept C64927066 @default.
• W3139148862 hasConcept C71924100 @default.
• W3139148862 hasConcept C86803240 @default.
• W3139148862 hasConcept C8891405 @default.
• W3139148862 hasConceptScore W3139148862C104317684 @default.
• W3139148862 hasConceptScore W3139148862C117643217 @default.
• W3139148862 hasConceptScore W3139148862C126322002 @default.
• W3139148862 hasConceptScore W3139148862C127848430 @default.
• W3139148862 hasConceptScore W3139148862C203014093 @default.
• W3139148862 hasConceptScore W3139148862C2776059313 @default.
• W3139148862 hasConceptScore W3139148862C2776090121 @default.
• W3139148862 hasConceptScore W3139148862C2776232967 @default.
• W3139148862 hasConceptScore W3139148862C2776256026 @default.
• W3139148862 hasConceptScore W3139148862C2777547418 @default.
• W3139148862 hasConceptScore W3139148862C2777589544 @default.
• W3139148862 hasConceptScore W3139148862C2777872185 @default.
• W3139148862 hasConceptScore W3139148862C2777891184 @default.
• W3139148862 hasConceptScore W3139148862C2778305200 @default.
• W3139148862 hasConceptScore W3139148862C2779338263 @default.
• W3139148862 hasConceptScore W3139148862C2781462825 @default.
• W3139148862 hasConceptScore W3139148862C501734568 @default.
• W3139148862 hasConceptScore W3139148862C502942594 @default.
• W3139148862 hasConceptScore W3139148862C54355233 @default.
• W3139148862 hasConceptScore W3139148862C64927066 @default.
• W3139148862 hasConceptScore W3139148862C71924100 @default.
• W3139148862 hasConceptScore W3139148862C86803240 @default.

• next